Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Supratherapeutic Vitamin C Supplementation in Class A Glucose-6-Phosphate Dehydrogenase (G6PD A) Deficiency and Pyruvate Kinase Deficiency (PKD)

NCT07612345 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT07612345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07612345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Supratherapeutic Vitamin C Supplementation in Class A Glucose-6-Phosphate Dehydrogenase (G6PD A) Deficiency and Pyruvate Kinase Deficiency (PKD)
Lead sponsor
University of Utah
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 15, 2026
Completion date
December 15, 2027
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose 6 phosphate dehydrogenase deficiency, pyruvate kinase deficiency